Health · 31 views
Safer stroke prevention strategies are needed for patients with atrial fibrillation after intracranial hemorrhage
Edoxaban did not reduce stroke or systemic embolism but increased major bleeding in high-risk patients with atrial fibrillation who had had an intracranial hemorrhage, according to results presented in a Hot Line session at ESC Congress…
AI Summary
Atrial fibrillation is the most common irregular heart rhythm and a leading cause of ischemic stroke. Oral anticoagulants such as edoxaban effectively prevent these strokes, but they increase bleeding risk. The risk is especially high for patients who have previously suffered an intracranial hemorrhage, which involves bleeding within or around the brain. Safer stroke‑prevention strategies are therefore needed for this high‑risk group.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patientsContinue reading
- Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar rangeContinue reading
- Wearing headphones during surgery may reduce nausea and vomiting afterwardContinue reading
- Adult ADHD; Encouraging Advance Care Planning; Hospital Closures in the U.S.Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow